In the context of insulin resistance, IL-6 interferes with insulin signaling pathways by activating serine kinases, such as c-Jun N-terminal kinase (JNK), which phosphorylate insulin receptor substrate proteins and disrupt insulin receptor signaling [39]. The gene discussed is INS; the disease is Insulin resistance.